Recovery and recurrence of left ventricular systolic dysfunction in patients with idiopathic dilated cardiomyopathy

Canadian Journal of Cardiology

Volumn 25, Issue 5, 2009, Pages

  Moon, Jeonggeun ^a   Ko, Young Guk ^a   Chung, Namsik ^a   Ha, Jong Won ^a   Kang, Seok Min ^a   Choi, Eui Young ^a   Rim, Se Joong ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Congestive heart failure; DCMP; Prognosis

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CONVALESCENCE; CORRELATION ANALYSIS; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPOTHESIS; MALE; PATIENT MONITORING; PATIENT SELECTION; RECURRENCE RISK; RECURRENT DISEASE; SYSTOLIC DYSFUNCTION;

EID: 65949101861     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(09)70497-0     Document Type: Article

References (20)

1. O'Connell JB, Bristow M. Economic impact of heart failure in the United States: Time for a different approach. J Heart Lung Transplant 1999;13:S107.
2. Hunt SA; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult. J Am Coll Cardiol 2005;46:e1-82.
3. McLaran CJ, Gersh BJ, Sugrue DD, et al. Tachycardia induced myocardial dysfunction. A reversible phenomenon? Br Heart J 1985;53:323-7.
4. Anselme F, Boyle N, Josephson M. Incessant fascicular tachycardia: A cause of arrhythmia induced cardiomyopathy. Pacing Clin Electrophysiol 1998;21:760-3.
5. Reza M, Hans M, Finn W. New insights into the pathogenesis of dilated cardiomyopathy: Possible underlying autoimmune mechanism and therapy. Autoimmunity Reviews 2004;3:277-84.
6. Sugrue DD, Rodeheffer RJ, Codd MB, et al. The clinical course of idiopathic dilated cardiomyopathy - a population based study. Ann Intern Med 1992;17:117-23.
7. Cetta F, Michels VV. The natural history and spectrum of idiopathic dilated cardiomyopathy including HIV and peripartum cardiomyopathy. Curr Opinion Cardiol 1995;10:332-8.
8. Khanlou H, Paltoo B, Forbes W. Echocardiographic parameters in reversible idiopathic dilated cardiomyopathy. Am J Med Sci 2000;319:366-9.
9. Schwarz F, Mall G, Zebe H, et al. Determinants of survival in patients with congestive cardiomyopathy: Quantitative morphologic findings and LV hemodynamics. Circulation 1984;70:923-8.
10. Mann-Rouillard V, Fishbein MC, Naqvi TZ, Don-Michael TA, Seigel RJ. Echocardiographic normalization of heart size and contractility in idiopathic dilated cardiomyopathy. Am J Cardiol 1999;83:131-2.
11. Nerheim P, Birger-Botkin S, Piracha L, Olshansky B. Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia. Circulation 2004;110:247-52.
12. Kuwata A, Ohashi M, Sugiyama M, Ueda R, Dohi Y. A case of reversible dilated cardiomyopathy after alpha-interferon therapy in a patient with renal cell carcinoma. Am J Med Sci 2002;324:331-4.
13. Danaher PJ, Cao MK, Anstead GM, Dolan MJ, DeWitt CC. Reversible dilated cardiomyopathy related to amphotericin B therapy. J Antimicrob Chemother 2004;53:115-7.
14. Kontani M, Izumiya Y, Shimizu M, et al. Acute reversible myocardial depression associated with sepsis. Intern Med 2003;42:60-5.
15. Avsar A, Dogan A, Tavli T. A rare cause of reversible dilated cardiomyopathy: Hypocalcemia. Echocardiography 2004;21:609-12.
16. Bezdah L, Slimene H, Kammoun M, Haddad A, Belhani A. Hypothyroid dilated cardiomyopathy. Ann Cardiol Angiol 2004;53:217-20.
17. Phillips SD, Warnes CA. Peripartum cardiomyopathy: Current therapeutic perspectives 2004;6:481-8.
18. Katstura J, Zhang X, Liu Y, et al. The cellular basis of pacing induced dilated cardiomyopathy: Myocyte cell loss and myocyte cellular reactive hypertrophy. Circulation 1995;92:2306-17.
19. Takahashi M, Tsutsui H, Kinugawa S, et al. Role of microtubules in the contractile dysfunction of myocytes from tachycardia-induced dilated cardiomyopathy. J Mol Cell Cardiol 1998;30:1047-57.
20. Spinale FG, Tomita M, Zellner JL, et al. Collagen remodeling and changes in LV function during development and recovery from supraventricular tachycardia. Am J Physiol 1991;261:308-18.